Table of Contents

Clinical Investigations

• You have access

  Regional Cerebral Blood Flow Response to Oral Amphetamine Challenge in Healthy Volunteers

  Michael D. Devous, Madhukar H. Trivedi and A. John Rush

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 535-542;
• You have access

  Dynamic and Static ^99mTc-ECD SPECT Imaging of Subacute Cerebral Infarction: Comparison with ¹³³Xe SPECT

  Kuniaki Ogasawara, Akira Ogawa, Masayuki Ezura, Hiromu Konno, Mamoru Doi, Kiyoshi Kuroda and Takashi Yoshimoto

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 543-547;
• You have access

  Statistical Brain Mapping of ¹⁸F-FDG PET in Alzheimer’s Disease: Validation of Anatomic Standardization for Atrophied Brains

  Kazunari Ishii, Frode Willoch, Satoshi Minoshima, Alexander Drzezga, Edward P. Ficaro, Donna J. Cross, David E. Kuhl and Markus Schwaiger

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 548-557;
• You have access

  Relationship Between the Location of the Most Severe Myocardial Perfusion Defects, the Most Severe Coronary Artery Stenosis, and the Site of Subsequent Myocardial Infarction

  Jaume Candell-Riera, Osvaldo Pereztol-Valdés, César Santana-Boado, Mario Missorici, Guillermo Oller-Martínez, Santiago Aguadé-Bruix, Joan Castell-Conesa, Marc Simó, María J. Díez-Castro and Jordi Soler-Soler

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 558-563;
• You have access

  Interobserver Reproducibility in Reporting on ^99mTc-DMSA Scintigraphy for Detection of Late Renal Sequelae

  David Ladron de Guevara, Philippe Franken, Carlos De Sadeleer, Hamphrey Ham and Amy Piepsz

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 564-566;
• You have access

  Usefulness of ^99mTc-Ciprofloxacin (Infecton) Scan in Diagnosis of Chronic Orthopedic Infections: Comparative Study with ^99mTc-HMPAO Leukocyte Scintigraphy

  Kerim Sonmezoglu, Meral Sonmezoglu, Metin Halac, Isik Akgün, Cüneyt Türkmen, Cetin Önsel, Bedii Kanmaz, Kirsor Solanki, Keith E. Britton and Ilhami Uslu

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 567-574;
• You have access

  Use of ²⁰¹Tl SPECT for Evaluation of Biologic Behavior in Pituitary Adenomas

  Takahiro Nakano, Kenichiroh Asano, Masahiko Tanaka, Toshio Takahashi, Hiroyuki Miura and Shigeharu Suzuki

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 575-578;
• You have access

  l-3-[¹²³I]Iodo-α-Methyl-Tyrosine SPECT in Non–Small Cell Lung Cancer: Preliminary Observations

  Pieter L. Jager, Harry J.M. Groen, Annija van der Leest, John W.G. van Putten, Remge M. Pieterman, Elisabeth G.E. de Vries and D. Albertus Piers

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 579-585;
• You have access

  Impact of ¹⁸F-FDG PET on Managing Patients with Colorectal Cancer: The Referring Physician’s Perspective

  Joubin Meta, Marc Seltzer, Christiaan Schiepers, Daniel H. Silverman, Maryam Ariannejad, Sanjiv S. Gambhir, Michael E. Phelps, Peter Valk and Johannes Czernin

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 586-590;
• You have access

  Increased Metabolic Activity in the Thymus Gland Studied with ¹⁸F-FDG PET: Age Dependency and Frequency After Chemotherapy

  Ingo Brink, Michael J. Reinhardt, Stefan Hoegerle, Carsten Altehoefer, Ernst Moser and Egbert U. Nitzsche

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 591-595;
• You have access

  Methylxanthine Sensitization of Human Colon Cancer Cells to ¹⁸⁶Re-Labeled Monoclonal Antibody

  Seigo Kinuya, Kunihiko Yokoyama, Miho Kudo, Yoshihito Kasahara, Katsutoshi Kobayashi, Shoji Motoishi, Katsuyuki Onoma, Hisashi Bunko, Takatoshi Michigishi and Norihisa Tonami

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 596-600;
• You have access

  Whole-Body Hybrid PET with ¹⁸F-FDG in the Staging of Non-Hodgkin’s Lymphoma

  Mitsuaki Tatsumi, Hitoshi Kitayama, Hiroyuki Sugahara, Naoki Tokita, Hironobu Nakamura, Yuzuru Kanakura and Tsunehiko Nishimura

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 601-608;
• You have access

  FDG PET Imaging in Patients with Lymphoma: A Clinical Perspective

  George M. Segall

  Journal of Nuclear Medicine April 1, 2001, 42 (4) 609-610;